Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & Administrative
Others
Ratios

Pasithea Therapeutics (KTTA) Other Non Operating Income (2022 - 2024)

Pasithea Therapeutics (KTTA) has disclosed Other Non Operating Income for 3 consecutive years, with $114407.0 as the latest value for Q2 2024.

  • Quarterly Other Non Operating Income fell 2.38% to $114407.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $378428.0 through Jun 2024, up 395.09% year-over-year, with the annual reading at $30376.0 for FY2025, N/A changed from the prior year.
  • Other Non Operating Income hit $114407.0 in Q2 2024 for Pasithea Therapeutics, down from $153218.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $153218.0 in Q1 2024 to a low of -$34367.0 in Q4 2022.
  • Historically, Other Non Operating Income has averaged $64843.5 across 3 years, with a median of $79703.5 in 2022.
  • Biggest five-year swings in Other Non Operating Income: tumbled 114.2% in 2023 and later skyrocketed 2498.53% in 2024.
  • Year by year, Other Non Operating Income stood at -$34367.0 in 2022, then surged by 441.0% to $117191.0 in 2023, then fell by 2.38% to $114407.0 in 2024.
  • Business Quant data shows Other Non Operating Income for KTTA at $114407.0 in Q2 2024, $153218.0 in Q1 2024, and $117191.0 in Q2 2023.